HomeAI · summaries
Storia in 2 fonti
ICMR licenses cancer, vaccine technologies to Emcure, Biological E
The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One drug candidate targets precancerous cervical cells, offering a safer treatment option. Two vaccine candidates will combat major bacterial gut infections. This initiative promotes government research into practical healthcare products.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
ICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E
ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate affordable healthcare innovations.
- ·
economictimes.indiatimes.com
ICMR licenses cancer, vaccine technologies to Emcure, Biological E
The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One…